ProCap Acquisition Corp (PCAP) 股票分析
金融服务ProCap Acquisition Corp
$10.26
+$0.00 (+0.00%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
ProCap Acquisition Corp operates primarily as a special purpose acquisition company (SPAC) focused on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses rather than maintaining significant ongoing operations. The entity is situated within the Financial Services sector and specifically classified under the industry of Shell Companies, a designation that implies the firm currently functions as a vehicle awaiting a business combination rather than a standalone operating business with traditional revenue streams. As of the latest available data, the company holds a market capitalization of $386.51M and has been incorporated in 2025 with its principal operations based in New York. Regarding scale metrics, the annual revenue figure is not publicly disclosed in the current reporting period, and the employee count is listed as N/A, which is typical for early-stage SPACs that have not yet completed their target mergers. The market capitalization of $386.51M indicates that the firm has successfully attracted public capital to facilitate a future acquisition, positioning it as a significant entity in the shell company landscape despite the lack of traditional revenue generation or a disclosed workforce size at this stage of its lifecycle.
财务健康
The company reports a net income of $5.66M for the trailing twelve months, while both revenue and EBITDA figures are not available due to the lack of significant operational activities prior to potential combinations. The absence of reported revenue figures in conjunction with a positive net income suggests a cost structure where expenses are likely minimal or offset by non-operating income, characteristic of shell companies that have not yet integrated with a target. Free cash flow data is not provided, indicating that the company's financial flexibility is currently derived from its trust account proceeds rather than operational cash generation. All three margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, which reflects the company's current status as a shell entity without active sales or cost of goods sold before a merger is finalized. In terms of balance sheet leverage, the company holds $1.07M in cash against a total debt obligation of $23,345, resulting in a debt-to-equity ratio that is listed as N/A due to the nature of its equity structure. This cash position relative to debt suggests a highly conservative balance sheet with negligible leverage risk prior to a business combination. The current ratio stands at 10.31, which indicates an exceptionally strong short-term liquidity position, suggesting the company has more than ten times the current assets required to cover its current liabilities. Return on equity and return on assets are listed as N/A, a standard metric presentation for SPACs that have not yet established a consolidated earnings base from an operating business, rendering these return metrics ineffective at evaluating management effectiveness at this specific juncture.
估值评估
The trailing twelve-month P/E ratio is recorded at 39.19, while the forward P/E ratio is listed as N/A, implying that future earnings expectations are not yet quantifiable based on current market consensus for a company that has not yet completed a merger. The price-to-book ratio is reported at -31.74, a negative figure that indicates the market valuation is significantly detached from traditional book value metrics, often seen in SPACs where the trust account value does not align with the reported book equity due to warrant liabilities or other financial instrument adjustments. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are both N/A, suggesting that standard valuation multiples are not applicable to a company that has not yet generated sales or positive EBITDA. The stock has traded within a 52-week range bounded by a high of $11.42 and a low of $9.01, placing the current trading price within this established volatility band. The beta value is not available, which means there is insufficient historical volatility data relative to the broader market to calculate a standard deviation or correlation coefficient for risk assessment. These valuation characteristics collectively paint a picture of a speculative asset where traditional fundamental valuation models require significant caution due to the lack of operating history and the specific accounting treatment of shell companies.
Growth & Income
Revenue growth and earnings growth rates for the year-over-year period are both listed as N/A, reflecting the fact that the company has not yet undergone a merger that would generate comparable growth metrics for analysis. Consequently, the comparison between earnings growth and revenue growth is not applicable, as neither metric exists in the current reporting period. ProCap Acquisition Corp does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating that the company reinvests all available capital into seeking a business combination target rather than returning cash to shareholders. The overall growth and income profile is defined by the potential for a binary event—completion of a merger—rather than organic growth or income generation from current operations. This structural profile is consistent with the business description of a shell company focused on effecting a merger or share exchange rather than delivering traditional financial returns until a target is acquired.
同行比较
ProCap Acquisition Corp (PCAP) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| ProCap Acquisition Corp | PCAP | $389.16M | 32.1 |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。ProCap Acquisition Corp的市盈率为32.1。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于ProCap Acquisition Corp
ProCap Acquisition Corp does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
公司简介以英文显示。